Deferred Tax Assets, Valuation Allowance of RHYTHM PHARMACEUTICALS, INC. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
RHYTHM PHARMACEUTICALS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • RHYTHM PHARMACEUTICALS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $381,166,000, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $381,166,000 +$55,663,000 +17% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $325,503,000 +$58,345,000 +22% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $267,158,000 +$49,901,000 +23% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $217,257,000 +$59,046,000 +37% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $158,211,000 +$24,615,000 +18% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $133,596,000 +$40,653,000 +44% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $92,943,000 +$45,264,000 +95% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $47,679,000 +$23,605,000 +98% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $24,074,000 +$3,586,000 +18% 31 Dec 2017 10-K 08 Mar 2019 2018 FY
Q4 2016 $20,488,000 31 Dec 2016 8-K 09 Nov 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.